Yili Wu

机构：Ningbo University, Ningbo Medical Center Lihuili Hospital, Ningbo University Affiliated Hospital

发表论文 5 篇 · 总被引 10 次 · h-index 2

代表论文

• TRF ‐16 Inhibits Lung Cancer Progression by Hindering the N6 ‐Methyladenosine Modification of CPT1A mRNA (2024 · Journal of Cellular and Molecular Medicine · 被引 6)
• LTF as a Potential Predictive Biomarker for Durable Benefit From First‐Line Chemo‐Immunotherapy in Small Cell Lung Cancer (2025 · Cancer Science · 被引 3)
• RET fusion-positive non-small cell lung cancer complicated with disseminated hematogenous tuberculosis during first-line Pralsetinib treatment: A case report (2023 · Research Square · 被引 1)
• SPDYE3 promotes cell cycle and LUSC progression by regulating the CDC25C/CDK1 pathway (2025 · The International Journal of Biochemistry & Cell Biology)
• RETRACTED: Circulating hsa_circ_0008797 as a novel liquid biopsy biomarker for lung cancer diagnosis (2023 · Research Square)